Company Profile

Versapeutics Inc
Profile last edited on: 2/8/2024      CAGE: 80VT7      UEI: EGSGJKXHKBN5

Business Identifier: Novel therapeutics based on latest neuroscience breakthroughs
Year Founded
2017
First Award
2021
Latest Award
2024
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

10210 Campus Point Drive Suite 150
San Diego, CA 92121
   (773) 702-1234
   info@versapeutics.com
   www.versapeutics.com
Location: Single
Congr. District: 52
County: San Diego

Public Profile

Now located in BioLab San Diego. VersaPeutics, Inc is a biotech startup structured around addressing the task of finding treatments for major disorders of the nervous system: developing novel antibody and small molecule therapeutics for neurological diseases and cancer based on cutting-edge discoveries in neuroscience and oncology. Founded by a UCSD professor, the firm has received three exclusive license agreements from that institution.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2024 2 NIH $1,925,167
Project Title: Pharmacokinetics and efficacy of intrathecal VersaMab-101 delivery foracute spinal cord injury
2023 2 NIH $2,636,674
Project Title: Preclinical Development of VERSAMAB-101 for Spinal Cord Injury
2023 1 NIH $489,628
Project Title: Developing therapeutic antibodies for Alzheimer's disease
2022 1 NIH $498,534
Project Title: Developing therapeutic antibodies for Alzheimer's disease

Key People / Management

  Haipeng Chen

  Miao Sun

  Yimin Zou

Company News

There are no news available.